Nigel Sheail has been appointed as a non-executive director on the board of Vernalis Plc. He is currently the head of corporate mergers and acquisitions and global head of pharma licensing at Hoffman-La Roche. Before joining Roche, Mr Sheail worked at GlaxoSmithKline Plc. He qualified as a chartered accountant at Ernst and Young.
Copyright 2011 Evernow Publishing